Skip to content

TaIwan Network of Targeted Temperature ManagEment for CARDiac Arrest Registry (TIMECARD)

TaIwan Network of Targeted Temperature ManagEment for CARDiac Arrest Registry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03578328
Acronym
TIMECARD
Enrollment
800
Registered
2018-07-06
Start date
2018-06-01
Completion date
2021-08-31
Last updated
2020-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Registry, Targeted Temperature Management

Brief summary

The goals of the study are to establish the study cohort and database for out-of-hospital cardiac arrest patients. Indications and factors influencing the application of hypothermia treatment on cardiac arrest patients will be analyzed. The prognostic evaluation modalities under hypothermia treatment will be evaluated for their accuracy and optimal time points. These finding and results could be applied in clinical practice in the future.

Detailed description

The importance of cardiopulmonary resuscitation has been emphasized in recent years. The chance of return of spontaneous circulation improves up to 70%. However, only 20 % of cardiac arrest patients can survive to hospital discharge because of post-cardiac arrest syndrome due to global ischemia-reperfusion injuries in cardiac arrest and resuscitation. Although there are some studies trying to predict the survival outcomes in cardiac arrest, the prediction variables are limited to the pre-arrest variables such as age, pre-morbidities. The impact of these variables on long term outcomes is neither clear nor well-defined. It is found that the chances of survival to discharge are significant different among different hospitals and districts. It implies that the intensive managements and treatment policies could influence the outcomes in cardiac arrest patients. However, the critical procedures or managements have not been systemically studied and remain undefined. Targeted temperature management based on hypothermia treatment changes the post-cardiac arrest care and improves the outcome in cardiac arrest patients. Under hypothermia treatment, the critical time points of evaluating prognosis are changed because of 24 hours maintaining cooling period and 12-18 hours rewarming period. The full neurological recovery cannot be evaluated at 24 hours after return of spontaneous circulation as the suggestion in old days without hypothermia treatment. The optimal time points for evaluating and predicting long term outcomes need to be re-defined. The accuracy of different modalities for outcome prediction also needed to be re-evaluated in the hypothermia treatment era. Early and precise prediction of good recovery and favorable outcomes are very important in determining the further intensive treatment strategies by physicians and family for cardiac arrest patients. The goals of the study are to establish the study cohort and database for out-of-hospital cardiac arrest patients. Indications and factors influencing the application of hypothermia treatment on cardiac arrest patients will be analyzed. The prognostic evaluation modalities under hypothermia treatment will be evaluated for their accuracy and optimal time points. These finding and results could be applied in clinical practice in the future.

Interventions

Temperature control to targeted temperature (32-36C) after return of spontaneous circulation after cardiac arrest and resuscitation

Sponsors

Taipei Medical University Shuang Ho Hospital
CollaboratorOTHER
Mackay Memorial Hospital
CollaboratorOTHER
Taipei Veterans General Hospital, Taiwan
CollaboratorOTHER_GOV
Taichung Veterans General Hospital
CollaboratorOTHER
Kaohsiung Veterans General Hospital.
CollaboratorOTHER
Changhua Christian Hospital
CollaboratorOTHER
National Cheng-Kung University Hospital
CollaboratorOTHER
Kaohsiung Medical University Chung-Ho Memorial Hospital
CollaboratorOTHER
Far Eastern Memorial Hospital
CollaboratorOTHER
National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≧18 2. Non-traumatic cardiac arrest 3. in- or out-of-hospital cardiac arrest requiring cardiopulmonary resuscitation 4. Comatose, defined as Glasgow Coma Score (motor+eye) \< 8 or cannot obey verbal command 5. Within 12 hours of return of spontaneous circulation

Exclusion criteria

* nil

Design outcomes

Primary

MeasureTime frameDescription
in-hospital mortalitywithin one year
favorable neurological outcome when hospital dischargewithin one yearCerebral Performance Category less than 3

Countries

Taiwan

Contacts

Primary ContactChien-Hua Huang, MD, PhD
chhuang730@gmail.com886-2-23562831
Backup ContactChien-Hua Huang
chhuang730@gmail.com886-2-23562831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026